Moderna’s mRNA cancer vaccine shows promise in preliminary study

Hasan

New member
Moderna’s mRNA cancer vaccine shows promise in preliminary study The shot combined with a Merck immunotherapy reduced the risk of relapse in people with skin cancer in a study, Moderna said
 
Üst